Revolutionary Study Unveils Sensoril® Ashwagandha: The Game-Changer for Women's Post-Menopausal Health

In an exciting breakthrough for women's health, Sensoril® Ashwagandha, a scientifically-supported ingredient from Kerry Group, has been shown to significantly enhance the quality of life for women post-menopause, according to a new clinical study published recently.

With the average woman potentially spending up to 40% of her life after menopause, ensuring these years are fulfilling and enjoyable is more important than ever. This groundbreaking study highlights Sensoril's unique capability to manage menopause-related symptoms and improve overall life quality, requiring only a minimum dosage of 250mg per day.

This new research adds to a substantial portfolio of 14 existing studies that affirm that Sensoril, derived from a standardized blend of ashwagandha root and leaf, is both safe and efficacious in promoting overall health.

Menopause is often accompanied by a myriad of distressing symptoms—such as hot flashes, mood swings, and sleep disturbances—that affect approximately 80% of women. Alarmingly, many of these symptoms are overlooked, even though they can have significant impacts on day-to-day life. In the Asia Pacific region alone, data shows that 64% of women face pre-menopausal symptoms that adversely affect their emotional wellbeing, and a staggering 62% of those who are perimenopausal, menopausal, or post-menopausal express interest in nutritional supplements to help ease their discomfort.

Despite the prevalence of these symptoms, menopause's effects on women's aging processes have been under-researched, resulting in critical gaps within women's healthcare. As we approach 2025, an estimated one billion women are expected to undergo menopause, emphasizing the urgent need for adequate solutions to tackle these gaps.

Interestingly, there has been a notable rise in the popularity of herbal and plant-based remedies as women increasingly seek natural alternatives to hormone replacement therapies. Sensoril® Ashwagandha emerges as an ideal solution that meets this demand, offering clinically demonstrated benefits that cater specifically to women.

The clinical study revealed remarkable improvements for participants, including:

Remarkable Improvements for Participants

- **24% reduction** in the severity and frequency of vasomotor symptoms like hot flashes, sweating, and night sweats. - **16% reduction** in psychosocial symptoms such as anxiety, poor memory, reduced productivity, and general life dissatisfaction. - **14% reduction** in various physical symptoms linked to sleep disturbances, fatigue, energy levels, and general aches. - **13% reduction** in alterations in sexual health, addressing issues such as decreased libido and vaginal dryness.

Dr. Monica Maria Olivares, RDA Director of Women & Infant Health at Kerry, emphasized the commitment to advancing women’s health. "Women deserve support that recognizes and meets their unique health needs at every life stage. This study further validates Sensoril as a safe and effective solution. At Kerry, we are dedicated to curating a selection of naturally sourced, clinically validated ingredients to support women's health throughout their lives.”

In conclusion, as the conversation around women’s health continues to evolve, Sensoril® Ashwagandha stands out as a promising ally in the pursuit of a healthier, happier life post-menopause.